Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Mar 15, 2026; 18(3): 116567
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.116567
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.116567
Table 6 Receiver operating characteristic performance (hepatocellular carcinoma vs cirrhosis)
| Biomarker | AUC (bootstrap 95%CI) | Optimal cutoff | Sensitivity (%) | Specificity (%) |
| hsa-miR-21-5p | 0.990 (0.974-1.000) | > 14.0 | 98.6 | 96.7 |
| hsa-miR-155-5p | 0.874 (0.809-0.930) | > 3.8 | 75.7 | 93.3 |
| LAIR-1+ T cell % | 0.833 (0.767-0.895) | > 55.9 | 52.9 | 100.0 |
| LAIR-1 MFI | 0.997 (0.990-1.000) | > 29.3 | 100.0 | 98.3 |
- Citation: Sherief DE, Shehata HH, Nosair N, Othman AAA, Sadaka E, Elgamal R. Dual-parameter liquid biopsy using plasma miR-21-5p and T cell LAIR-1 mean fluorescence intensity for hepatocellular carcinoma diagnosis in a high-risk Egyptian cohort. World J Gastrointest Oncol 2026; 18(3): 116567
- URL: https://www.wjgnet.com/1948-5204/full/v18/i3/116567.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i3.116567